Postkoital'naya kontratseptsiya
- Authors: Manusharova R.A1, Cherkezova E.I1
-
Affiliations:
- Issue: No 12 (2013)
- Pages: 14-16
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/282244
- ID: 282244
Cite item
Open Access
Access granted
Abstract
Postcoital or emergency contraception is a single contraception aimed at the prevention of unwanted pregnancy, which is not suitable for permanent use. At the same time, in certain situations, emergency contraception is the only way to prevent unwanted pregnancy and prevents abortion. The article describes the currently used methods of postcoital contraception.
Full Text
References
- Манушарова Р.А. Применение Норпланта при миоме матки. Int J immunoreabilitation 2003;1:87.
- Манушарова Р.А., Черкезова Э.И. Современные пролонгированные методы контрацепции в лечении миомы матки // Лечащий врач 2004. № 1. С. 62-5.
- Хомасуридзе А.Г., Манушарова Р.А. Применение пролонгированных контрацептивов // Акушер. и гинекол. 1998. № 2. С. 45-6.
- Прилепская В.Н. Внутриматочная контрацепция. М., 2000.
- Barbosa J, Bakos O, Olssen SE, et al. Ovarian function during use of a Levonorgestrel - releasing IUD. Contraception. 1990;42:51-66.
- Barrington J, Bowen-Simpkins F. Management of refractory pre-menstrual syndroms using subcutaneous oestradiol implants and levonorgestrel intrauterine systeme. Obstet. Gynaecol. 1997;17(4):416-17.
- Critchley H, Wang H, Kelly R, et al. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel - releasing intrauterine system. Hum. Reprod. 1998;13(5):1210-710.
- Fedele L, Bianchi S, Raffaelli R, et al. Treatment of adenomyosis-associated menorrhagia with a Levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68:426-29.
- Fedele L, Bianchi S, Raffaelli R, et al. Treatment of adenomyosis-associated menorrhagia with a Levonorgestrel-releasing intrauterine device. Fertil Steril 2001;75:485-88.
- Johansson E. Future aspects of the Levonorgestrel-releasing intrauterine system. Gynecol Forum 1998;3(3):311-32.
- Klein N, Soules M. Endocrine changes of the perimenopause. Clin Obstet Gynecol 1998;41(4):912-20.
- Nilsson C.G., Labteenmaki P., Luukkainen T. Ovarian function in ammenorrhoea and menstruating users of a Levonorgestrel - releasing intrauterine device. Fertil. Steril. 1984; 41:52-88.
- Pakarinen P, Labteenmaki P, Rutanen E. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor- binding protein-1. Acta Obstet Gynaecol 1999;78(5): 423-28.
- Robinson GE. Bounds W, Kubba AA, et al. Functional jvarian cysts associated with Levonorgestrel - releasing intrauterine device. Brit J Fam Plann 1989;14:131-32.
- Sivin J, Alvarez F, Diaz J, et al. Intrauterine contraception with qt copper and with Levonorgestrel: a randomised study of the Tcu 380 Ag and Levonorgestrel 20ug device. Contraception 1984;30:443-56.
- Vercellini A, Aimi G, Panazza S, et al. Levonorgestrel - utleasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril 1999;72:505-08.
Supplementary files
